Frigerio F - Search Results

1

Food semantics on pro-anorexia websites in Italy.

Chinello A, Parma F, Frigerio F, Manila Galli C, Richichi V, Zappa LE, Dell'Orletta F, Boschetti F. Chinello A, et al. Among authors: frigerio f. Riv Psichiatr. 2020 Sep-Oct;55(5):297-300. doi: 10.1708/3457.34462. Riv Psichiatr. 2020. PMID: 33078021

2

A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour.

Lissoni P, Barni S, Fossati V, Ardizzoia A, Cazzaniga M, Tancini G, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Support Care Cancer. 1995 May;3(3):194-7. doi: 10.1007/BF00368890. Support Care Cancer. 1995. PMID: 7655780 Clinical Trial.

3

Interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors in patients with solid tumors are not correlated.

Lissoni P, Rizzo V, Barni S, Rescaldani R, Rovelli F, Biondi A, Archili C, Frigerio F, Tancini G. Lissoni P, et al. Among authors: frigerio f. Int J Biol Markers. 1989 Jul-Sep;4(3):170-3. doi: 10.1177/172460088900400307. Int J Biol Markers. 1989. PMID: 2614085

4

[Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area].

Colombo A, Crispino S, Barni S, Paolorossi F, Frigerio F, Tancini G, Lissoni P, Placa F, Mazzola P, Nava S, et al. Colombo A, et al. Among authors: frigerio f. Radiol Med. 1987 Oct;74(4):334-7. Radiol Med. 1987. PMID: 3671803 Italian.

5

Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.

Lissoni P, Barni S, Cazzaniga M, Ardizzoia A, Rovelli F, Tancini G, Brivio F, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Oncology. 1995 Nov-Dec;52(6):439-42. doi: 10.1159/000227507. Oncology. 1995. PMID: 7478427

6

Anal squamous cell carcinoma arising on radio-dermatitis cured with chemotherapy alone: case report.

Barni S, Frigerio F, Lissoni P, Crispino S, Paolorossi F. Barni S, et al. Among authors: frigerio f. Tumori. 1987 Aug 31;73(4):423-4. doi: 10.1177/030089168707300418. Tumori. 1987. PMID: 3660479

7

Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapy.

Lissoni P, Meregalli S, Fossati V, Barni S, Tancini G, Barigozzi P, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Tumori. 1993 Jun 30;79(3):198-201. doi: 10.1177/030089169307900308. Tumori. 1993. PMID: 8236504 Clinical Trial.

8

Pineal-opioid system interactions in the control of immunoinflammatory responses.

Lissoni P, Barni S, Tancini G, Fossati V, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Ann N Y Acad Sci. 1994 Nov 25;741:191-6. doi: 10.1111/j.1749-6632.1994.tb39659.x. Ann N Y Acad Sci. 1994. PMID: 7825805

9

A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer.

Lissoni P, Meregalli S, Fossati V, Paolorossi F, Barni S, Tancini G, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Tumori. 1994 Dec 31;80(6):464-7. doi: 10.1177/030089169408000611. Tumori. 1994. PMID: 7900237 Clinical Trial.

10

Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapy.

Lissoni P, Barni S, Tancini G, Brivio F, Cardellini P, Vaghi M, Fossati V, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Tumori. 1993 Aug 31;79(4):246-9. doi: 10.1177/030089169307900403. Tumori. 1993. PMID: 8249176 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page